| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.26B | +4.3% |
| Cost of Revenue | $5.42B | +107.0% |
| R&D Expense | $3.29B | +65.5% |
| SG&A Expense | $1.13B | +99.6% |
| Operating Income | $9.42B | -29.2% |
| Pre-tax Income | $9.57B | -27.9% |
| Income Tax | $1.21B | +12.0% |
| Net Income | $8.36B | -31.5% |
| EPS (Basic) | $21.26 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.21B | -53.2% |
| Accounts Receivable | $1.39B | -56.4% |
| Inventory | $949.0M | -34.1% |
| Current Assets | $13.43B | -16.4% |
| Total Assets | $25.86B | +4.8% |
| Current Liabilities | $4.92B | -46.1% |
| Total Liabilities | $6.74B | -36.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.98B | -63.4% |
| Capital Expenditures | $400.0M | +40.8% |
| Investing Cash Flow | -$5.18B | +39.3% |
| Financing Cash Flow | -$3.45B | -295.0% |
| Free Cash Flow | $4.58B | -65.6% |
| -29.9% |
| EPS (Diluted) | $20.12 | -28.9% |
| Stockholders' Equity |
| $19.12B |
| +35.2% |